Evidence map›Paper›PMID 29495270›Full record

ReviewAntibiotics (Basel, Switzerland)2018

Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy.

Panos G Kalatzis, Daniel Castillo, Pantelis Katharios, Mathias Middelboe

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Prophage-Derived Molecules as Anti-Antibiotics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. The bacteriovorous ciliateFrontiers in microbiology · 2026
    Article
  8. The ecology and evolution of microbial immune systems: a look on the wild vibrio side.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Bacteriophage-based strategies for biocontrol and treatment of infectious diseases.Computational and structural biotechnology journal · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. The trade-off ofFrontiers in microbiology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Panos G KalatzisMarine Biological Section, University of Copenhagen, DK-3000 Helsingør, Denmark. panos.kalatzis@bio.ku.dk.ORCID 0000-0003-3029-783X
Daniel CastilloMarine Biological Section, University of Copenhagen, DK-3000 Helsingør, Denmark. daniel.castillo@bio.ku.dk.
Pantelis KathariosInstitute of Marine Biology, Biotechnology and Aquaculture, Hellenic Centre for Marine Research, 71500 Crete, Greece. katharios@hcmr.gr.ORCID 0000-0001-9905-5068
Mathias MiddelboeMarine Biological Section, University of Copenhagen, DK-3000 Helsingør, Denmark. mmiddelboe@bio.ku.dk.ORCID 0000-0002-9587-9171

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A global distribution in marine, brackish, and freshwater ecosystems, in combination with high abundances and biomass, make vibrios key players in aquatic environments, as well as important pathogens for humans and marine animals. Incidents of

Indexed as

aquaculturebacteriophagesbiological controlinteractionsmarine vibriosphage therapyvibriosis

Identifiers

PMID29495270
PMCPMC5872126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.